Annual Congress was host to a renal cell carcinoma abstract session. Dr. Huebner-Resch presented her team’s initial real-world experience using [89 Zr]Zr-girentuximab PET/CT in the routine evaluation ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
"Milford Regional Medical Center is a highly respected community hospital with a strong commitment to clinical excellence," said Peter Ferrari, President of Shields Health. We are proud to collaborate ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Renu Eapen discussing the optimal management of de-novo ...
A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.
Detection of prostate cancer and its recurrence is challenging as it is a heterogeneous disease and methods such as PET imaging and measurement of biochemical response using prostate specific membrane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results